TASIA THOMPSON: Open Payments
NPI 1427680990 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,333 in 142 payments from 23 companies in 2025. Trend: 2023 $2,059 · 2024 $2,394 · 2025 $2,333
Food & beverage: $2,333
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $423 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $315 |
| Novo Nordisk Inc | 18 | $269 |
| AstraZeneca Pharmaceuticals LP | 6 | $260 |
| Corium, LLC | 10 | $154 |
| Amgen Inc. | 13 | $154 |
| Axsome Therapeutics, Inc. | 8 | $136 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $76 |
| Lilly USA, LLC | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
Products named: CAPLYTA, VRAYLAR, UBRELVY, TAGRISSO, Azstarys, Auvelity, Ozempic, Wegovy.
Industry payments across KY — which companies pay providers there.
